Regeneron Pharma begins human trials of Covid-19 antibody ‘cocktail’
Team Udayavani, Jun 13, 2020, 10:03 AM IST
US-based Regeneron Pharmaceuticals has begun human trials of its antibody ‘cocktail’ as a treatment for Covid-19
The antibody which is called REGN-COV2, contains an antibody made by Regeneron and a second isolated from humans who recovered from Covid-19.
George Yancopoulos .Chief Scientific Officer, said“If it goes perfectly well, within a week or two we will move to the second phase. Within a month or so of that we will have clear data that this is or isn’t working. By the end of summer, we could have sufficient data for broad utilization”
Regeneron said its treatment could be useful even if a Covid-19 vaccine is developed since the elderly and people with compromised immune systems often do not respond well to vaccines.
The firm also plans to study REGN-COV2 for preventing the infection in people at high risk of exposure.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Kambala: Tradition and modernity in coastal Karnataka
Dairy farmers in K’taka border areas selling milk to Kerala for higher price!
Kadaba: ‘Notion that only English-medium education leads to success is misleading’
Udupi: ‘Team Taulava’ takes charge to preserve endangered ancient monuments
Mangaluru: Special children add colour to Deepavali with hand-painted diyas
MUST WATCH
Latest Additions
Akhilesh Yadav attacks BJP on demonetisation anniversary
SC notice to Karnataka, DK Shivakumar on CBI plea against withdrawal of consent by state govt
DeMo paved way for monopolies by devastating MSMEs, informal sector: Rahul on note ban anniversary
Will remain active in politics till my last breath: JD(S) patriarch & ex-PM Deve Gowda
Comply with order allowing minority student to attend St Stephen’s College: HC tells DU
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.